Research and Development of Machine Translation Technology and Product Enhancements
First written in FY2017-Q1. 23 of 37 entries say "Restated". Latest entry: 2026-10-15.
The whole theme swung hardest in 2023: 2 of 18 companies on the "Worse" side.
0 other companies' latest entry also says "First stated".
- 2026-10-15First statedFinancial Results Presentation
「開発体制の100% AI化を達成」
Metareal Agentsを共通基盤として、固定の製品型から離れ、人間の関与を抑えた自律型製品開発へ進化させる新たな長期施策が示された。 - FY2027-H1RestatedAnnual report
「R&D expenses for the interim consolidated accounting period were ¥40.693 million. There were no material changes in the status of the group’s R&D activities during the interim consolidated accounting period.」
The company continued its R&D activities and reported expenses of ¥40.693 million for the interim consolidated accounting period. It reconfirmed that there were no material changes in the status of these activities. - FY2026ReframedAnnual report
「During the fiscal year under review, we worked to enhance the functionality and quality of translation and AI products, including T-4OO and Rakuyaku, and conducted research and development related to Metareal AI, the underlying technology platform. In the following fiscal year, we will develop solutions to further advance the transformation into agentic AI in 4 areas: translation, pharmaceuticals, architecture and business creation.」
The focus of research and development has become more specific, moving from functionality improvements for T-4OO, Rakuyaku and Metareal AI to advancing the transformation into agentic AI in 4 areas: translation, pharmaceuticals, architecture and business creation. Research and development expenses were ¥109.340 million. - FY2026-H1RestatedAnnual report
「Research and development activity during the interim consolidated accounting period under review totaled ¥67.717 million. There were no material changes in the status of the group’s research and development activities during the interim consolidated accounting period under review.」
Research and development activities continued, with activity during the interim consolidated accounting period totaling ¥67.717 million. The company reconfirms that there were no material changes in the status of these activities. - FY2025ReframedAnnual report
「During the fiscal year under review, we worked on “Rakuyaku” for the pharmaceutical industry as a vertical AI agent specialized by sector, “Shikiho AI” and “Metareal DD” for the financial sector, “PR AI” for the public relations sector, and prototype development of T-4OO using generative AI technology. In the following fiscal year, we will develop additional features to achieve product-market fit (PMF) for released AI products and develop vertical agents for new industry sectors.」
The focus of research and development has shifted from improving translation accuracy and basic voice-translation technologies to sector-specific vertical AI agents, generative AI products and additional development aimed at achieving PMF. Research and development expenses were ¥248.355 million. - FY2025-H1RestatedAnnual report
「Research and development activity during the interim consolidated accounting period under review totaled ¥95.450 million. There were no material changes in the status of the group’s research and development activities during the interim consolidated accounting period under review.」
Research and development activities continued, with activity during the interim consolidated accounting period totaling ¥95.450 million. The company reconfirms that there were no material changes in the status of these activities. - FY2025-Q1RestatedAnnual report
「Research and development activity during the cumulative first quarter under review totaled ¥50.017 million. There were no material changes in the status of the group’s research and development activities during the cumulative first quarter under review.」
Research and development activities continued, bringing the cumulative total for the first quarter to ¥50.017 million. The company reconfirms that there were no material changes in the status of these activities. - FY2024ReframedAnnual report
「During the fiscal year under review, we focused on improving the accuracy of T-4OO and Onyak, developing customized solutions using generative AI, and providing services and contract development mainly through the Metareal AI project. In the following fiscal year, research and development will focus on improving the accuracy of document and voice translation using generative AI and creating new services and developing products through the Metareal AI project.」
The focus of automated translation research and development broadened from improving the accuracy of T-4OO and Onyak to customization using generative AI and service and contract development through Metareal AI. For the following fiscal year, the company presents a policy of focusing on document and voice translation using generative AI and developing new services. - FY2024-Q3RestatedAnnual report
「Research and development activity during the cumulative third quarter under review totaled ¥103.173 million. There were no material changes in the status of the group’s research and development activities during the cumulative third quarter under review.」
Research and development activities continued, with activity during the cumulative third quarter under review totaling ¥103.173 million. The company reconfirms that there were no material changes in the status of these activities. - FY2024-Q1RestatedAnnual report
「Research and development activity during the cumulative first quarter under review totaled ¥51.999 million. There were no material changes in the status of the group’s research and development activities during the cumulative first quarter under review.」
Research and development activities continued, with activity stated as ¥51.999 million. The company reconfirms that there were no material changes in the status of these activities. - FY2023-Q3RestatedAnnual report
「Research and development activity during the cumulative third quarter under review totaled ¥220.388 million. There were no material changes in the status of the group’s research and development activities during the cumulative third quarter under review.」
Research and development activities continued, bringing the cumulative total to ¥220.388 million. The company reconfirms that there were no material changes in the status of these activities. - FY2023-Q2RestatedAnnual report
「Research and development activity during the cumulative second quarter under review totaled ¥129.315 million. There were no material changes in the status of the group’s research and development activities during the cumulative second quarter under review.」
Research and development activities continued, with the cumulative total stated as ¥129.315 million. The company reconfirms that there were no material changes in the status of these activities. - FY2023-Q1RestatedAnnual report
「Research and development activity during the cumulative first quarter under review totaled ¥53.219 million. There were no material changes in the status of the group’s research and development activities during the cumulative first quarter under review.」
Research and development activities continued, with activity stated as ¥53.219 million. The company reconfirms that there were no material changes in the status of these activities. - FY2022-Q3RestatedAnnual report
「Research and development activity during the cumulative third quarter under review totaled ¥193.783 million. There were no material changes in the status of the group’s research and development activities during the cumulative third quarter under review.」
Research and development activities continued, bringing the cumulative total to ¥193.783 million. The company explicitly states that there were no material changes in the status of these activities. - FY2022-Q2RestatedAnnual report
「Research and development activity during the cumulative second quarter under review totaled ¥145.460 million. There were no material changes in the status of the group’s research and development activities during the cumulative second quarter under review.」
Research and development activities continued, with the cumulative total recorded at ¥145.460 million. The company explicitly states that there were no material changes in the status of these activities. - FY2022-Q1RestatedAnnual report
「Research and development activity during the cumulative first quarter under review totaled ¥71.871 million. There were no material changes in the status of the group’s research and development activities during the cumulative first quarter under review.」
Research and development activities continued, with research and development activity during the quarter stated as ¥71.871 million. The company explicitly states that there were no material changes in the status of these activities. - FY2021RestatedAnnual report
「During the fiscal year under review, we continued from the previous period to investigate and research AI technology to achieve a further breakthrough in document translation accuracy in the MT business, as well as to research the basic elemental technologies required to develop T-4PO, a wearable device that provides real-time voice interpretation. Total research and development activity during the fiscal year under review was ¥118.049 million.」
The company continues research into AI technology and the basic technologies for T-4PO. Annual research and development activity totaled ¥118.049 million, up from ¥11.475 million in the previous fiscal year, but no new completion milestones are provided. - FY2021-Q3RestatedAnnual report
「Total research and development activity during the cumulative third quarter under review was ¥23.107 million. There were no material changes in the status of the group’s research and development activities during the cumulative third quarter under review.」
Research and development activities continued, bringing the cumulative total to ¥23.107 million. The company explicitly states that there were no material changes in the status of these activities. - FY2021-Q2RestatedAnnual report
「Research and development activity during the cumulative second quarter under review totaled ¥15.780 million. There were no material changes in the status of the group’s research and development activities during the cumulative second quarter under review.」
Research and development activities continued, bringing the cumulative total to ¥15.780 million. The company explicitly states that there were no material changes in the status of these activities. - FY2021-Q1RestatedAnnual report
「Research and development activity during the cumulative first quarter under review totaled ¥8.330 million. There were no material changes in the status of the group’s research and development activities during the cumulative first quarter under review.」
The company continues research and development related to machine translation, with research and development activity during the quarter stated as ¥8.330 million. There were no material changes in the status of these activities. - FY2020RestatedAnnual report
「From the fiscal year under review, we began investigating and researching AI technology to achieve a further breakthrough in document translation accuracy in the MT business, as well as researching the basic elemental technologies required to develop T-4PO, a wearable device that provides real-time voice interpretation. Total research and development activity during the fiscal year under review was ¥11.475 million.」
The company continues its AI research to improve document translation accuracy and its research into the basic technologies for T-4PO. Annual research and development activity totaled ¥11.475 million, but no new milestones for development completion or accuracy improvements are provided. - FY2020-Q3RestatedAnnual report
「From the first quarter, we began investigating and researching AI technology to achieve a further breakthrough in document translation accuracy in the MT business, as well as researching the basic elemental technologies required to develop T-4PO, a wearable device that provides real-time voice interpretation. Total research and development activity during the cumulative third quarter under review was ¥7.781 million.」
The company continues to research AI technology to improve document translation accuracy and the basic technologies for T-4PO. Cumulative research and development activity is stated as ¥7.781 million, but no new milestones, such as development completion, are provided. - FY2020-Q1AdvancedAnnual report
「From the first quarter under review, we began investigating and researching AI technology to achieve a further breakthrough in document translation accuracy in the MT business, as well as researching the basic elemental technologies required to develop T-4PO, a wearable device that provides real-time voice interpretation. Total research and development activity during the cumulative first quarter under review was ¥1.582 million.」
The company began researching AI technology to further improve document translation accuracy and the basic technologies for T-4PO, a wearable device for real-time voice interpretation. Total research and development activity is stated as ¥1.582 million. - FY2019-Q1RestatedAnnual report
「Orders for the high-accuracy machine translation system T-4OO ver.2, developed through upfront investment in the previous fiscal year, increased substantially.」
Orders for T-4OO ver.2, whose accuracy was improved through upfront investment in the previous fiscal year, have increased. No specific new milestones for research and development or product improvements are provided. - FY2018RestatedAnnual report
「During the fiscal year under review, a breakthrough occurred in our machine translation development, and English-to-Japanese translation accuracy reached 95% in the 5 major fields of industrial translation: medicine, chemistry, legal, finance and IT. The T-4OO(ver.2), released at the end of November 2017, applies high-accuracy machine translation in these 5 fields. We also shifted management policy by substantially increasing upfront development investment, with a focus on applying high-accuracy translation to other major fields of industrial translation as a top management priority.」
The annual report reconfirms the previously reported achievement of 95% accuracy in the 5 major fields and its application to T-4OO(ver.2). - FY2018-Q3AdvancedAnnual report
「During the cumulative third quarter under review (1 March 2017 to 30 November 2017), a breakthrough occurred in our machine translation development, and English-to-Japanese translation accuracy reached 95% in the 5 major fields of industrial translation: medicine, chemistry, legal, finance and IT.」
The company reports concrete progress in machine translation development, with English-to-Japanese translation accuracy reaching 95% in the 5 major fields of medicine, chemistry, legal, finance and IT. A footnote explains that this level corresponds to the “nearly equivalent to human” accuracy target set at the time of listing for achievement by 2025. - FY2018-Q2ReframedAnnual report
「The translation industry is undergoing a sudden and rapid, revolutionary paradigm shift far beyond previous expectations, driven by the practical application of neural machine translation (NMT) technology with dramatically improved accuracy. During the cumulative second quarter under review (1 March 2017 to 31 August 2017), our group prepared fundamental changes to respond to this rapid transformation.」
The focus of the explanation has broadened from improving conventional automated translation accuracy and developing NMT to responding to industry changes resulting from the practical application of NMT and preparing for fundamental transformation. - FY2018-Q1AdvancedAnnual report
「During the cumulative first quarter under review (1 March 2017 to 31 May 2017), we increased upfront investment and strengthened development further, with a view to innovating machine translation technology using neural networks.」
The company states that it increased upfront investment and strengthened development of neural-network-based machine translation technology. No figures or milestones, such as an accuracy improvement rate or development completion, are provided. - FY2017-Q3RestatedAnnual report
「We have continued to advance research and development in automated translation while working to provide services that support the more efficient handling of translation work for companies undergoing globalization.」
The company’s performance review continues to present a policy of advancing research and development in automated translation. - FY2017-Q3RestatedAnnual report
「In the MT business, revenue was ¥199.101 million, down 0.9% year on year, and segment profit was ¥25.682 million, down 62.5%, owing to a temporary decline in new orders as sales efforts shifted to newly hired sales personnel and the company actively pursued additional automated translation development.」
The company says it actively pursued additional automated translation development, but provides no specific milestones, such as figures for accuracy improvements or development completion. - FY2017-Q2RestatedAnnual report
「Alongside making the planned upfront investment in development to improve automated translation accuracy,」
The company reconfirmed its commitment to improving automated translation accuracy and continuing research and development. The planned upfront investment is mentioned, but no figures for accuracy improvements or development-completion milestones are provided. - FY2017-Q1First statedAnnual report
「We have continued to improve the automated translation accuracy and functionality of “熟考” and “熟考Z” translation products.」
The company’s performance review also indicates a policy of advancing research and development in automated translation.